We’ve just departed from Dubai having completed a very successful Arab Health exposition. The Vasomedical booth included displays, graphics and demonstrations from all segments of our company profile, including EECP® and ECP therapy systems, Biox’ new ECG Holter and ambulatory blood pressure monitors and our wireless MobiCare™ patient monitoring products. Our booth location was ideal, we were in one of the convention center’s main concourses and was extremely busy throughout the whole show. We were joined in the booth by our associates from Biox and VSK, Vasomedical’s newest joint venture for marketing and sales of EECP/ECP technology globally. Together we welcomed many visitors from all over the Middle East, as well as visitors from North America, Europe and India.
This show allowed us to increase our exposure in the Middle East. There are treatment centers in the Kingdom of Saudi Arabia, the United Arab Emirates, Egypt, Jordan, the Sudan, Bahrain, Oman and Israel. Many physicians in the region are familiar with the clinical benefits of the therapy and are very interested in bringing the technology to their local hospitals and clinics.
Biox – MobiCare™ wireless patient monitoring products attracted a high level of interest at the show. The flexibility to un-tether the patient from the monitor using Bluetooth technology is very unique. Along with the added feature of remote viewing capabilities away from the clinical setting by physicians, healthcare workers and patient families, it was evident that MobiCare™ was one of the most interesting new products seen by many of the attendees.
As Medical Fair Asia comes to a close in Singapore on Sept 11th, 2014, many of us are reflecting on this day. 13 years ago millions of people went to sleep not knowing the world was about to change forever. We continue to think about the people we lost that day and will keep them and their families in our thoughts, our hearts and our prayers.
Medical Fair Asia has been another successful meeting. There were constant visitors to our booth, they came from all over Southeast Asia to participate in this show, which is one of the largest medical industry conferences in the Asian market. Hospital and healthcare administrators, physicians and many distributors came to our booth wanting to see our products; they were especially interested in MobiCare®, a unique wireless patient monitoring system with flexible communications capabilities.
MobiCare frees the patients from typical bedside monitoring and allows them the freedom to move about the room and nearby areas with comfort and safety. In addition, the ability to perform remote viewing functions by authorized personnel expanded the potential capabilities to meet multiple needs of a quickly growing and more challenging healthcare marketplace. The need for safe and reliable monitoring for patients is no longer limited to bedside monitoring in the hospital, nor does it stop when the patient is discharged. There is a rapidly growing need to provide better medical services in some of the most unique situations and MobiCare’s communication flexibility meets that monitoring challenge head on.
Though there have been a few scattered EECP Therapy systems throughout the region, EECP Therapy is not generally well known in Southeast Asia. Some of our distributors visited us to discuss opportunities and projects they are currently working on and plans to expand awareness in their designated territories. While most healthcare professionals in the region are not aware of the therapy, our participation in international shows expands awareness of the therapy and is creating a bigger audience for its acceptance. Many new distributors visited our booth and expressed interest in becoming our authorized representative in their respective countries for EECP Therapy, as well as our Biox ECG Holter and ambulatory monitoring products.
We also had an opportunity to learn more about the regulatory and typical marketing practices in many of the countries represented here. Having a better understanding and establishing connections in this region will help us ensure we approach the markets in the best way possible to create opportunities to generate revenue, while controlling and monitoring expenses.
Make sure to stay tuned for more tales from the road as we continue to showcase and educate the healthcare industry about EECP Therapy technology and our other offerings.
We’ve all heard that exercising keeps the heart healthy – whether it’s a run, yoga class or cycling. But how much exercise is healthy and can too much be harmful?
According to a recent piece by MedPage Today, “too much of a good thing” can become a reality, and one must be tuned in to his or her limits. It looks like moderate exercise may be the way to go, even for healthy patients.
The article states:
“Research involving stable chronic heart disease (CHD) patients found daily strenuous exercise to be associated with a more than twofold increased risk for cardiovascular mortality compared with moderate (two- to four-times a week) exercise (2.36, 95% CI 1.05-5.34).”
This is not an excuse to skip your exercise though! Researchers found that moderate, regular exercise is important for maintaining a healthy heart. Widely accepted guidelines recommend 30-60 minutes of moderate intensity aerobic activity five to seven days per week.
Dr. Kai Ruffmann is a cardiologist based in Germany who has been recommending and administering EECP® Therapy treatments for his patients for more than ten years. He has treated more than 250 patients in the hospital he worked at in the Black Forest region, and recently opened his own cardiology and internal medicine clinic in Baden-Baden.
Though various sites in Germany have provided EECP Therapy for many years, Dr. Ruffmann is the first German provider to get one of the German health insurance companies – a sickness fund – to provide reimbursement coverage for EECP Therapy, which is a huge win.
Germany has a universal multi-payer healthcare system with two main types of health insurance: “Law-enforced health insurance” (Gesetzliche Krankenversicherung), also known as sickness funds, and “Private” (Private Krankenversicherung). The “law enforced health insurance” is available for people who fall below a certain income level, and is provided through private non-profit sickness funds at common rates for all members. This insurance is paid for with joint employer-employee contributions.
The recently updated 2013 European Society of Cardiology Guidelines granted a IIa Level of Recommendation for EECP Therapy in treating refractory angina patients and this upgrade in status helps with reimbursement from insurance companies. At Vasomedical, we know that EECP Therapy changes lives, and we are very pleased to see that additional insurance companies around the world are beginning to accept this treatment and reimburse for it.
We appreciate Dr. Ruffmann’s commitment to his patients and his support of EECP Therapy on their behalf. We will continue to work with him to expand reimbursement coverage for more patients in Germany and Europe.
The Reverend has been receiving EECP Therapy since 2004 as a preventative treatment to ensure his system is functioning to its best capacity and he has optimal blood flow. Due to a hectic schedule which includes a great deal of travel and public speaking, he believes maintaining his system and focusing on his circulation and healthy diet are critical.
According to Rev. Beckwith:
“It is essential, if someone is going to do their life work, if someone’s going to release their gifts, their talents, their capacities – which is what I teach – they need to be healthy. It’s a sad thing to see someone who has a great dream within their heart and soul but can’t manifest it because they’re sick all the time.”
In the video, the Reverend discusses not only his excellent experience with EECP Therapy, but relays the positive experiences of several members of his congregation as well.
What if you found out your heart’s age was older than your current age? Would you take action?
According to a recent study involving 3,000 patients, researchers in Spain compared a relatively new tool to measure heart-disease risk, called Heart Age, against a commonly used heart risk-assessment tool to gauge what participant’s “heart age” was.
The positive news: people took action! Participants who were told that their heart age was greater than their chronological age showed health improvements a year later, more so than those in the comparison group.
As you may know, more than 700,000 Americans suffer from heart attacks each year, and a quarter of all people in the U.S. die from heart disease, according to the Centers for Disease Control and Prevention. Heart disease is a major health issue which requires us to all to be proactive rather than reactive about our health. Apps such as Heart Age, prod us to take action and have demonstrated that they are successful in prompting lifestyle changes.
As we come to a close on American Heart Month don’t let apps simply scare you into action but think of them as a jumping off point for taking a healthy initiative. Try to eat well, get 30 minutes of exercise a day, and take the stairs instead of the elevator – simple life changes can make a world of difference.
Tell us: what apps do you use to maintain a healthy lifestyle?